EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms of Doxorubicin-Induced Cardiac Senescence and Potential Therapeutic Strategies

Yanli Bai, Wen Yang, Zirong Wang, Qianqian Yang, Zhongping Zhang, Jialong Liu, Yafang Qi, Dongling Liu

Biomolecules · 12.08.2026 · 16 (8) · 1180

DOI: 10.3390/biom16081180 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 12.08.2026. Verfasst von Yanli Bai und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Gansu University of Chinese Medicine, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Doxorubicin, Cellular Senescence, Cardiotoxicity, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Gansu Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX) is a widely used anthracycline chemotherapeutic agent; however, its clinical application is limited by dose-dependent cardiotoxicity, which can result in progressive cardiac dysfunction and heart failure. Increasing evidence indicates that DOX-induced cardiotoxicity is closely associated with premature cardiac senescence, a pathological process distinct from physiological cardiac aging. DOX induces senescence-associated alterations in multiple cardiac cell populations, disrupting cardiac homeostasis and contributing to pathological remodeling. In this review, we summarize current advances in DOX-induced cardiac senescence, focusing on the contributions of different cardiac cell types, the underlying molecular mechanisms, and emerging therapeutic strategies. We further discuss the challenges and future perspectives for developing effective interventions that alleviate cardiac senescence while preserving the anticancer efficacy of DOX. Understanding the mechanisms driving DOX-induced cardiac senescence may provide new opportunities to develop effective cardioprotective strategies and improve long-term cardiac outcomes after chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCellular SenescenceCardiotoxicityAntibiotics, AntineoplasticHumansAnimalsMyocytes, Cardiac

Stichwörter der Autor:innen

cardiac senescencecardiotoxicitydoxorubicinsenescence-targeted therapy

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Gansu University of Chinese Medicine, Lanzhou 730000, China.
  • School of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.
  • School of Bioengineering and Technology, Tianshui Normal University, Tianshui 741000, China.
  • Gansu Pharmaceutical Industry Innovation Research Institute, Gansu University of Chinese Medicine, Lanzhou 730000, China.
  • Northwest Collaborative Innovation Center for Traditional Chinese Medicine, Lanzhou 730000, China.

Förderung

  • National Natural Science Foundation of China
  • Gansu Provincial Science and Technology Department

Zitieren

APA

Bai, Y., Yang, W., Wang, Z., Yang, Q., Zhang, Z., Liu, J., Qi, Y., & Liu, D. (2026). Mechanisms of Doxorubicin-Induced Cardiac Senescence and Potential Therapeutic Strategies. Biomolecules, 16(8), 1180. https://doi.org/10.3390/biom16081180

Vancouver

Bai Y, Yang W, Wang Z, Yang Q, Zhang Z, Liu J, et al. Mechanisms of Doxorubicin-Induced Cardiac Senescence and Potential Therapeutic Strategies. Biomolecules. 2026;16(8):1180. doi:10.3390/biom16081180

BibTeX
@article{Bai2026,
  author = {Bai, Yanli and Yang, Wen and Wang, Zirong and Yang, Qianqian and Zhang, Zhongping and Liu, Jialong and Qi, Yafang and Liu, Dongling},
  title = {Mechanisms of Doxorubicin-Induced Cardiac Senescence and Potential Therapeutic Strategies},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1180},
  doi = {10.3390/biom16081180}
}
Kostenlos starten →